INT158766

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.73
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 3
Disease Relevance 1.59
Pain Relevance 0.28

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (GRN) mitochondrion (GRN) extracellular space (GRN)
extracellular region (GRN)
GRN (Homo sapiens)
Pain Link Frequency Relevance Heat
Somatostatin 24 89.00 High High
imagery 174 78.88 Quite High
positron emission tomography 72 40.80 Quite Low
anesthesia 8 5.00 Very Low Very Low Very Low
lidocaine 4 5.00 Very Low Very Low Very Low
cerebral cortex 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
local anesthetic 2 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Neuroendocrine Cancer 46 99.96 Very High Very High Very High
Gastrinoma 4 98.12 Very High Very High Very High
Metastasis 101 98.04 Very High Very High Very High
Disease 130 97.12 Very High Very High Very High
Cancer 427 96.36 Very High Very High Very High
Lung Cancer 22 35.32 Quite Low
Small Cell Lung Cancer 20 8.48 Low Low
Colon Cancer 126 5.00 Very Low Very Low Very Low
Thyroid Neoplasm 106 5.00 Very Low Very Low Very Low
Skin Cancer 78 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
METHODS: Searches for all studies related to GEP NETs, NETs and carcinoid tumours in Medline and abstracts from international meetings.
Localization (related) of GEP
1) Confidence 0.73 Published 2009 Journal Aliment. Pharmacol. Ther. Section Body Doc Link 19298583 Disease Relevance 0.09 Pain Relevance 0
Another approach to intraoperative localization of GEP neuroendocrine tumors is use of the gamma detection probe for radioguided surgery.
Localization (localization) of GEP associated with neuroendocrine cancer
2) Confidence 0.06 Published 2009 Journal World J Surg Oncol Section Body Doc Link PMC2653072 Disease Relevance 0.78 Pain Relevance 0.14
Therefore, the ability to detect and localize GEP neuroendocrine tumor tissue is paramount to the effectiveness of surgical treatment and was revolutionized by Krenning's landmark description of radiolabeled octreotide scintigraphy using 111In-DTPA-D-Phe1-octreotide and 123I-Tyr3-octreotide, which both specifically target somatostatin receptors [688].
Localization (localize) of GEP associated with neuroendocrine cancer and somatostatin
3) Confidence 0.05 Published 2009 Journal World J Surg Oncol Section Body Doc Link PMC2653072 Disease Relevance 0.72 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox